No abstract

No abstract

To expand the available donor pool, many organ procurement organizations and transplant programs have begun to consider severe acute respiratory syndrome coronavirus (SARS-CoV-2) nucleic acid test positive candidates. 1 It is becoming increasingly clear that not all donors with a positive nucleic acid amplification test for SARS-CoV-2 are contagious, and some of these organs can be transplanted with careful selection. 2,3 Data from 31 kidney transplants from living donors with resolved COVID-19 in India showed the safety of this approach. 4 However, it is unknown whether kidneys from donors with active COVID-19 can also be safely transplanted. 3,5 Beyond the "active" infection designation, it is clinically possible to risk stratify donors with COVID-19 based on additional parameters such as clinical history and radiologic or laboratory findings. Here we present a case and 210-day outcome of a successful kidney transplantation from otherwise medically suitable SARS-CoV-2 PCR-positive deceased donors.

No abstract

No abstract